Episode 81. Current COVID Risk Assessment: BA.2.86 Variant, Boosters, and More
MedCram
BA 2.86 variant: Risk assessment and impact on immunity
This chapter explores the BA 2.86 variant of COVID-19, discussing its risk assessment, genetic differences, and impact on immunity. It clarifies confusion regarding its infection capability in individuals with previous COVID-19 infection or vaccination. The chapter also examines the mutations present in the variant and the effectiveness of monoclonal antibodies against it.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
